Prospective capillaroscopy-based study on transition from primary to secondary Raynaud’s phenomenon: preliminary results
Submitted: 22 May 2013
Accepted: 9 October 2013
Published: 31 October 2013
Accepted: 9 October 2013
Abstract Views: 3564
PDF: 1587
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- G. Tansir, P. Kumar, A. Pius, S.K. Sunny, M. Soneja, Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus , Reumatismo: Vol. 71 No. 2 (2019)
- A. Alunno, O. Bistoni, E. Bartoloni Bocci, S. Caterbi, B. Bigerna, A. Pucciarini, A. Tabarrini, R. Mannucci, D. Beghelli, B. Falini, R. Gerli, IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome , Reumatismo: Vol. 65 No. 4 (2013)
- M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García, Clinical profile of patients with lupus psychosis in a Colombian cohort , Reumatismo: Vol. 74 No. 2 (2022)
- M. Govoni, N. Rizzo, G. Castellino, M. Padovan, F. Trotta, Neuropsychiatric systemic lupus erythematosus: where are we now? , Reumatismo: Vol. 57 No. 4 (2005)
- L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni, Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive? , Reumatismo: Vol. 60 No. 3 (2008)
- C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri, Adherence to cervical cancer screening in an Italian SLE cohort , Reumatismo: Vol. 63 No. 1 (2011)
- A. Tincani, G. Fontana, C. Mackworth-Young, The history of antiphospholipid syndrome , Reumatismo: Vol. 74 No. 4 (2022)
- M.B. Ates, S. Karup, S. Ugurlu, Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency , Reumatismo: Vol. 75 No. 4 (2023)
- A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli, Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus , Reumatismo: Vol. 62 No. 3 (2010)
- M.G. Portuesi, M. Lancia, L. Ciuffreda, Problem of differential diagnosis between Crohn’s disease and colitis in Behçet’s disease: a case report , Reumatismo: Vol. 62 No. 2 (2010)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
You may also start an advanced similarity search for this article.